A single supratherapeutic dose of ridaforolimus does not prolong the QTc interval in patients with advanced cancerRichard M. Lush, Anthony W. Tolcher, K. Cerchio et al.|Cancer Chemotherapy and Pharmacology|2012Cited by 2
A single supratherapeutic dose of ridaforolimus does not prolong the QTc interval in patients with advanced cancer Richard M. LushAmita PatnaikDaniel SullivanKyriakos P. PapadopoulosMichele Trucksis • Jacqueline McCreaKristine CerchioXiaodong LiMark StrohDiana SelverianKeith Orford • Scot EbbinghausNancy AgrawalMarian IwamotoJohn A. WagnerAnthony TolcherRichard M. Lush, Dohme Corp, Danielle Sullivan et al.|Unknown|2012Cited by 0
To assess the effect of ridaforolimus on the QTc interval in patients with advanced cancer.Danielle Sullivan, A. W. Tolcher, Amita Patnaik et al.|Journal of Clinical Oncology|2011Cited by 0